Figure 1From: Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapyFlow diagram of patient selection in the study. Flow diagram depicting the number of patients and reasons for dropout (red boxes) and the number of patients remaining after each adjustment step (grey boxes). Tumors of 249 patients could be evaluated for the presence of the BRCA1-likeCGH and BRCA2-likeCGH pattern. The blue boxes at the bottom indicate the number of patients assigned to the BRCA1-likeCGH, BRCA2-likeCGH and BRCA-likeCGH categories. aCGH, array comparative genomic hybridization.Back to article page